Concepedia

Alejandro Cané

AC

15

Publications

394

Citations

12

H-Index

2008

Active since

Affiliations

Pfizer (United States)(Current)

Kaiser Permanente

University of California, Berkeley

University of Alabama at Birmingham

Pfizer (Canada)

Alejandro Cané is an author at Pfizer (United States) specializing in infection control, medicine, and epidemiology.

ORCID

Top concepts

Publications per year

2008–2024

15

Publications

15

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

Manuela Di Fusco, Mary M. Moran, Alejandro Cané et al. · Journal of Medical Economics · 2021 · 56 citations · Full text

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older Adults

Joseph A. Lewnard, Katia Bruxvoort, Heidi Fischer et al. · Clinical Infectious Diseases · 2021 · 49 citations

Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use

Rotem Lapidot, Yazdani B. Shaik-Dasthagirisaheb, Sarah Hinderstein et al. · PEDIATRICS · 2023 · 37 citations

Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States

Manuela Di Fusco, Kinga Marczell, Kristen A. Deger et al. · Journal of Medical Economics · 2022 · 36 citations · Full text

Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population

Derek Lytle, Ana Gabriela Grajales Beltrán, Johnna Perdrizet et al. · Human Vaccines & Immunotherapeutics · 2023 · 33 citations · Full text

, , +20

Rows per page

1–5 of 15